Transposagen Overview

  • Year Founded
  • 2003

Year Founded

  • Status
  • Acquired/​Merged

  • Employees
  • 20


  • Latest Deal Type
  • M&A

Transposagen General Information


Developer of biotechnology drugs intended to improve drug discovery and development research. The company is biotechnology-based and provides genetically modified rat models to create improved preclinical models, performing cell engineering and in vitro and in vivo oncology studies for clients, enabling researchers to discover drugs and treat diseases.

Contact Information

Ownership Status
Financing Status
Formerly Accelerator/Incubator backed
Primary Industry
Other Industries
Other Pharmaceuticals and Biotechnology
Corporate Office
  • 535 West Second Street
  • Suite L102
  • Lexington, KY 40508
  • United States
+1 (859) 000-0000

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Transposagen Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
5. Merger/Acquisition 01-Jan-2018 00.000 Completed Generating Revenue
4. Grant 21-Jun-2013 00.00 00.000 Completed Generating Revenue
3. Angel (individual) 18-Jul-2012 00000 00.000 Completed Generating Revenue
2. Angel (individual) 20-Dec-2011 $725K $725K Completed Generating Revenue
1. Accelerator/Incubator Completed Startup
To view Transposagen’s complete valuation and funding history, request access »

Transposagen Comparisons

HQ Location
Total Raised
Post Valuation
Developer of biotechnology drugs intended to improve drug discovery and development research. The company is biotechnolo
Lexington, KY
20 As of 2015
000000&0 00.000


it, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim a
Centennial, CO
000.00 0000-00-00


m dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt
Cambridge, MA
000 As of 0000
000000 - 000 00000
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Transposagen Competitors (50)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Novus Biologicals Formerly PE-Backed Centennial, CO 000000&0
Intellia Therapeutics Formerly VC-backed Cambridge, MA 000 00000 000000 - 000 00000
EdiGene Venture Capital-Backed Beijing, China 000 00000 00000000000 00000
ERS Genomics Corporate Backed or Acquired Dublin, Ireland 00 000000&0
OncoResponse Venture Capital-Backed Houston, TX 00 00000 0000000000 00000
You’re viewing 5 of 50 competitors. Get the full list »

Transposagen Patents

Transposagen Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
JP-2018099136-A Site-specific enzymes and methods of use Inactive 16-Nov-2012 00000000
US-10844361-B2 Site-specific enzymes and methods of use Active 16-Nov-2012 0000000000 00
US-20200199553-A1 Site-specific enzymes and methods of use Active 16-Nov-2012 0000000000
AU-2019216699-B2 Site-specific enzymes and methods of use Active 16-Nov-2012 0000000000 0
AU-2013344375-B2 Site-specific enzymes and methods of use Active 16-Nov-2012 C12N9/22 0
To view Transposagen’s complete patent history, request access »

Transposagen Signals

Growth Rate

0.80% Weekly
Weekly Growth 0.80%, 93rd %
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers


Similarweb Unique Visitors


Majestic Referring Domains


PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Transposagen Former Investors (2)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Johns Hopkins Technology Ventures Accelerator/Incubator 000 0000 000000 0
National Institutes of Health Government 000 0000 000000 0
To view Transposagen’s complete investors history, request access »

Transposagen FAQs

  • When was Transposagen founded?

    Transposagen was founded in 2003.

  • Who is the founder of Transposagen?

    Eric Ostertag Ph.D is the founder of Transposagen.

  • Where is Transposagen headquartered?

    Transposagen is headquartered in Lexington, KY.

  • What is the size of Transposagen?

    Transposagen has 20 total employees.

  • What industry is Transposagen in?

    Transposagen’s primary industry is Biotechnology.

  • Is Transposagen a private or public company?

    Transposagen is a Private company.

  • What is Transposagen’s current revenue?

    The current revenue for Transposagen is 000000.

  • How much funding has Transposagen raised over time?

    Transposagen has raised $1.08M.

  • Who are Transposagen’s investors?

    Johns Hopkins Technology Ventures and National Institutes of Health have invested in Transposagen.

  • Who are Transposagen’s competitors?

    Novus Biologicals, Intellia Therapeutics, EdiGene, ERS Genomics, and OncoResponse are some of the 50 competitors of Transposagen.

  • When was Transposagen acquired?

    Transposagen was acquired on 01-Jan-2018.

  • Who acquired Transposagen?

    Transposagen was acquired by Hera BioLabs.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »